DIAG-723

N/A

Report date: 2025/06/19 11:38:46

Base Information

Drug NameDIAG-723

Drug Alias NameDIAG-723

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionActivin receptor-like kinase 1 agonistsBone morphogenetic protein receptor type-2 agonists

TargetsActivin receptor-like kinase 1Bone morphogenetic protein receptor type-2

Therapy Area/IndicationsTelangiectasia, Hereditary HemorrhagicPulmonary Arterial Hypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDiagonal Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesDiagonal Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsTelangiectasia, Hereditary HemorrhagicPulmonary Arterial Hypertension

Inactive IndicationsN/A

Other Information

ATC CodeN/A